Literature DB >> 9348139

Predictors of survival in 171 patients with systemic sclerosis (scleroderma).

Z Nagy1, L Czirják.   

Abstract

Predictors of survival were determined in 171 patients with systemic sclerosis by univariate analysis, and the Cox proportional hazards model using both cross sectional data at entry into the follow-up and time-dependent follow-up data. Clinical and laboratory data were evaluated from 1982 to the end of 1993. The presence of diffuse scleroderma, kidney and cardiac involvements were unfavourable prognostic signs in both the univariate analysis, and the Cox proportional hazards models. The Cox model, using the variables detected at study entry, indicated that pericarditis, and anaemia were bad prognostic signs. Analysis with time dependent data has not been reported in systemic sclerosis. The appearance of pigmentation disturbances, anaemia, and respiratory failure during the follow-up also caused a poor prognosis of the disease by the Cox model. In the stepwise selection models, diffuse scleroderma, internal organ manifestations including renal, and cardiac involvements were predominantly selected as the most unfavourable factors for survival. As to the extent of skin involvement and internal organ manifestations, the general behaviour of the disease seems to be similar throughout the world. The early appearance of pericarditis and pigmentation disturbances at study entry are bad prognostic signs.

Entities:  

Mesh:

Year:  1997        PMID: 9348139     DOI: 10.1007/bf02238937

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  25 in total

1.  A survival study of patients with scleroderma diagnosed over 30 years (1953-1983): the value of a simple cutaneous classification in the early stages of the disease.

Authors:  A J Barnett; M H Miller; G O Littlejohn
Journal:  J Rheumatol       Date:  1988-02       Impact factor: 4.666

2.  Cardiac score. A semiquantitative measure of cardiac involvement that improves prediction of prognosis in systemic sclerosis.

Authors:  P J Clements; P A Lachenbruch; D E Furst; H E Paulus; M G Sterz
Journal:  Arthritis Rheum       Date:  1991-11

3.  Clinical findings in 61 patients with progressive systemic sclerosis.

Authors:  L Czirják; A Bokk; G Csontos; G Lörincz; G Szegedi
Journal:  Acta Derm Venereol       Date:  1989       Impact factor: 4.437

4.  Survival with scleroderma. II. A life-table analysis of clinical and demographic factors in 358 male U.S. veteran patients.

Authors:  T A Medsger; A T Masi
Journal:  J Chronic Dis       Date:  1973-10

5.  Survival in scleroderma.

Authors:  R Bennett; R Bluestone; P J Holt; E G Bywaters
Journal:  Ann Rheum Dis       Date:  1971-11       Impact factor: 19.103

6.  Survival analysis of 118 patients with systemic sclerosis.

Authors:  L Czirják; Z Nagy; G Szegedi
Journal:  J Intern Med       Date:  1993-09       Impact factor: 8.989

Review 7.  Systemic sclerosis.

Authors:  V D Steen
Journal:  Rheum Dis Clin North Am       Date:  1990-08       Impact factor: 2.670

8.  Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee.

Authors: 
Journal:  Arthritis Rheum       Date:  1980-05

9.  Prediction of survival in progressive systemic sclerosis by multivariate analysis of clinical features.

Authors:  J Wynn; N Fineberg; L Matzer; X Cortada; W Armstrong; J C Dillon; E L Kinney
Journal:  Am Heart J       Date:  1985-07       Impact factor: 4.749

10.  Predictors of survival in systemic sclerosis (scleroderma).

Authors:  R D Altman; T A Medsger; D A Bloch; B A Michel
Journal:  Arthritis Rheum       Date:  1991-04
View more
  10 in total

1.  European multicentre study to define disease activity criteria for systemic sclerosis. I. Clinical and epidemiological features of 290 patients from 19 centres.

Authors:  A Della Rossa; G Valentini; S Bombardieri; W Bencivelli; A J Silman; S D'Angelo; M M Cerinic; J F Belch; C M Black; R Becvar; P Bruhlman; F Cozzi; L Czirják; A A Drosos; B Dziankowska; C Ferri; A Gabrielli; R Giacomelli; G Hayem; M Inanc; N J McHugh; H Nielsen; R Scorza; E Tirri; F H van den Hoogen; P G Vlachoyiannopoulos
Journal:  Ann Rheum Dis       Date:  2001-06       Impact factor: 19.103

2.  Autologous stem cell transplantation in the treatment of systemic sclerosis: report from the EBMT/EULAR Registry.

Authors:  D Farge; J Passweg; J M van Laar; Z Marjanovic; C Besenthal; J Finke; H H Peter; F C Breedveld; W E Fibbe; C Black; C Denton; I Koetter; F Locatelli; A Martini; A V N Schattenberg; F van den Hoogen; L van de Putte; F Lanza; R Arnold; P A Bacon; S Bingham; F Ciceri; B Didier; J L Diez-Martin; P Emery; W Feremans; B Hertenstein; F Hiepe; R Luosujärvi; A Leon Lara; A Marmont; A M Martinez; H Pascual Cascon; C Bocelli-Tyndall; E Gluckman; A Gratwohl; A Tyndall
Journal:  Ann Rheum Dis       Date:  2004-08       Impact factor: 19.103

Review 3.  Systemic sclerosis: a world wide global analysis.

Authors:  Paola Coral-Alvarado; Aryce L Pardo; Natalia Castaño-Rodriguez; Adriana Rojas-Villarraga; Juan-Manuel Anaya
Journal:  Clin Rheumatol       Date:  2009-03-11       Impact factor: 2.980

4.  Predictors of inpatient mortality in patients with systemic sclerosis: a case control study.

Authors:  Shiv T Sehra; Andrew Kelly; Joshua F Baker; Chris T Derk
Journal:  Clin Rheumatol       Date:  2016-04-07       Impact factor: 2.980

5.  Skin thickness progression rate: a predictor of mortality and early internal organ involvement in diffuse scleroderma.

Authors:  Robyn T Domsic; Tatiana Rodriguez-Reyna; Mary Lucas; Noreen Fertig; Thomas A Medsger
Journal:  Ann Rheum Dis       Date:  2010-08-02       Impact factor: 19.103

Review 6.  Practical approach to the therapy of systemic sclerosis.

Authors:  L Czirják
Journal:  Z Rheumatol       Date:  2004-12       Impact factor: 1.372

7.  Disease severity of 100 patients with systemic sclerosis over a period of 14 years: using a modified Medsger scale.

Authors:  A J Geirsson; F A Wollheim; A Akesson
Journal:  Ann Rheum Dis       Date:  2001-12       Impact factor: 19.103

8.  Derivation and validation of a prediction rule for two-year mortality in early diffuse cutaneous systemic sclerosis.

Authors:  Robyn T Domsic; Svetlana I Nihtyanova; Stephen R Wisniewski; Michael J Fine; Mary Lucas; C Kent Kwoh; Christopher P Denton; Thomas A Medsger
Journal:  Arthritis Rheumatol       Date:  2014-06       Impact factor: 10.995

9.  Clinical and genetic factors predictive of mortality in early systemic sclerosis.

Authors:  Shervin Assassi; Deborah Del Junco; Kari Sutter; Terry A McNearney; John D Reveille; Andrew Karnavas; Pravitt Gourh; Rosa M Estrada-Y-Martin; Michael Fischbach; Frank C Arnett; Maureen D Mayes
Journal:  Arthritis Rheum       Date:  2009-10-15

10.  Inhibition of Chk2 promotes neuroprotection, axon regeneration, and functional recovery after CNS injury.

Authors:  Matthew J Taylor; Adam M Thompson; Sharif Alhajlah; Richard I Tuxworth; Zubair Ahmed
Journal:  Sci Adv       Date:  2022-09-14       Impact factor: 14.957

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.